Markets hit new highs as risk appetite builds. Arm reverses after weak guidance, Canadian Natural posts $1.35B profit, gold rises and oil slides.
Markets hit new highs as risk appetite builds. Arm reverses after weak guidance, Canadian Natural posts $1.35B profit, gold rises and oil slides.

The TSX is moving higher this morning, while the TSX Venture Index is also advancing, as Canadian equities track a global risk‑on rally driven by record highs in U.S. markets. The S&P 500 and Nasdaq continue to push deeper into uncharted territory as investors lean into growth and technology, encouraged by easing geopolitical tensions and strong corporate earnings. In contrast, European markets are under pressure, with the FTSE 100 falling sharply as investors rotate away from U.K. equities.

Commodities are mixed. Oil prices continue to slide on optimism around a temporary truce in the Middle East and hopes of increased crude flows, while gold is pushing higher above US$4,750 as investors maintain some defensive exposure. Copper is edging higher on infrastructure and electrification demand, natural gas is slipping, and Bitcoin is pulling back in Canadian‑dollar terms after a strong recent run.

Market numbers

TSX: Up (+0.36%), 34,103.38

TSXV: Up (+1.53%), 1,011.15

DOW: Up (+0.02%), 49,914.9

NASDAQ: Up (+0.20%), 28,618.2

FTSE 100: Down (‑1.24%), 10,316.83

In the headlines

  • Arm reverses sharply after guidance disappoints: Arm Holdings (NDAQ:ARM) — the semiconductor design firm at the heart of global chip architecture — saw its shares swing sharply lower after initially jumping on earnings, as investors reacted negatively to guidance that came in below expectations. The move highlights how sensitive AI‑linked stocks remain to forward outlooks.
  • Canadian Natural Resources posts $1.35B Q1 profit: Canadian Natural Resources (TSX:CNQ) — one of the country’s largest oil and gas producers — reported first‑quarter profit of $1.35 billion, supported by resilient production and elevated energy prices tied to Middle East disruptions.
  • Novo Nordisk and Eli Lilly gain as obesity market expands: Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) — the pharmaceutical leaders in weight‑loss and diabetes treatments — moved higher after new analysis suggested demand for obesity pills could significantly expand the overall market, reinforcing long‑term growth expectations.

Currencies

USD: Down (‑0.01%), $0.7330

GBP: Down (‑0.26%), $0.5379

EUR: Down (‑0.20%), $0.62315

JPY: Up (+0.01%), ¥114.709

AUD: Down (‑0.13%), $1.0116

Bitcoin (BTC/CAD): Down (‑1.37%), 109,580.9

(Conversion to C$1)

Commodities

Copper: Up (+0.57%), 6.23546

Gold: Up (+1.08%), 4,741.81

WTI: Down (‑3.06%), 92.15

Natural Gas: Down (‑1.18%), 2.691

To stay up-to-date on all of your market news head to Stockhouse.com.

Join the discussion: Find out what everybody’s saying about ARM and Novo Nordisk for May 7th, 2026, on Stockhouse’s stock forums and message boards.


More From The Market Online

@ the Bell: TSX springs back to life

Canada’s main stock index rebounded on Friday after an early sharp decline, lifted by gains in...

Are AI stocks still a good investment?

AI-driven semiconductor demand is creating an opening for quantum computing, and D Wave (NYSE:QBTS) is positioned as an early player.
Nintendo Switch 2 image via Nintendo

Nintendo’s Switch 2 success faces investor pressure as costs rise

Nintendo (OTC Pink:NTDOF) Switch 2 has been a success, but it’s reportedly being sold at a loss, raising concerns about profitability.

Drone company spreads wings across US Department of War

Draganfly (CSE/NASDAQ:DPRO) will supply two units within the US Department of War with its Flex FPV drone systems.